get Hepatitis C news that will help you feel and BE better!
AOL Daily Finance article: Achillion's 'Very Promising' New Drug for Hepatitis C
Achillion's 'Very Promising' New Drug
for Hepatitis C

http://www.dailyfinance.com/
By MELLY ALAZRAKI Posted 4:45 PM 04/14/10:
Achillion (ACHN), a small biopharmaceutical that focuses on infectious disease, knows the story about hepatitis C very well. A liver disease caused by the hepatitis C virus (HCV), viral hepatitis is the leading cause of liver cancer and the most common reason for a liver transplant.
An estimated 4.1 million Americans are infected with the HCV with 17,000 new cases annually.
And the disease causes an estimated 10,000 to 12,000 deaths annually in the U.S.

POSTED: 7:51PM | 21 July 2010 | Share a link with Billy Drop!

DailyFinance link: read the article here:
Robert Schimmel with Holly DeSantis at her popular Hell's Kitchen coffee/biscotti shop Bis.Co.Latte.
Cancer in remission, now comic Robert Schimmel
needs a liver transplant

san diego examiner.com January 28, 11:14 PMManhattan
(Local Music Examiner Jim Bessman)
Robert Schimmel, who has had way more than his share of troubles over the years, dropped another bombshell near the end of his appearance this morning on Howard Stern ’s Sirius satellite radio show, when he revealed that he suffers from cirrhosis and now needs a liver transplant.
Schimmel, who has documented his bout with non-Hodgkin lymphoma in his inspiring book Cancer On $5 A Day* *(Chemo Not Included): How Humor Got Me Through The Toughest Journey Of My Life, was on Stern to promote his weekend gigs at New York comedy club Comix. But he had other issues than health to focus on first, as it was his initial visit to Stern’s show since his arrest last year on allegations of domestic violence.

POSTED: 13:01PM | 20 February 2010 | Part of complete coverage on Vital Signs

examiner link: read the article here:
Life with Hepatitis C for London's teenage 'It Girl'
Life with Hepatitis C for London's teenage 'It Girl'

C NEWS: By Anouk Lorie for CNN (December 24, 2009 9:26 a.m. EST)
Recently named London's "It Girl" by society magazine Vanity Fair, 18-year-old Jazzy de Lisser is said to have it all. She is beautiful and affluent, her best friends include Sting's daughter, Coco Sumner, and she is often compared to another famous British trend-setter, Kate Moss.
Yet underneath the glitz and glamour of a privileged lifestyle, de Lisser has fought a lifelong battle with what is termed the "silent killer" -- Hepatitis C -- an infectious blood-borne virus that attacks and scars the liver.
At the age of three, blood tests revealed that de Lisser's mother -- fashion designer Serena Bute -- had unknowingly passed on the deadly disease to her daughter.

POSTED: 13:01PM | 26 December 2009 | Part of complete coverage on Vital Signs

see video now: watch it here: CNN link: read the article here:
theHepatitisCepidemic.com can help New Jersey
NJ warns nearly 3,000 to get tested for hep B

C NEWS: TOMS RIVER, N.J. (Map, News) - New Jersey officials on Thursday advised nearly 3,000 people who share a doctor to get tested after five cancer patients who visited the physician were found to have hepatitis B.
Ocean County health officials said two cases of hepatitis B were confirmed in late February as connected with the office of Dr. Parvez Dara, an oncologist with offices in Toms River and Manchester, near the Jersey Shore.

POSTED: 13:01PM | 2 April 2009 | www.topix.com/health

more: read the article here:
Hepatitis C Virus revealed
Inhibiting the Hepatitis C Virus

C NEWS: Opening up new treatment possibilities, researchers from Scripps Institute have found molecules that prevent Hepatitis C viral production.
POSTED: 04:09AM | 16 March 2009 | www.hepatitiscentral.com

more: read the article here:
FDA and Schering-Plough working together on Hepatitis C
FDA Approves New Indication for PegIntron plus Ribavirin for Certain Patients Who Failed Prior Hepatitis C Treatment

C NEWS: On March 11, Schering-Plough announced that the U.S. Food and Drug Administration has approved new labeling for pegylated interferon alfa-2b (PegIntron) plus ribavirin (Rebetol brand) combination therapy for treatment of chronic hepatitis C in certain patients with compensated liver disease who did not achieve sustained response to prior treatment.
POSTED: 14:20PM | 13 March 2009 | www.hivandhepatitis.com

more: read the article here:

About sharing:

This is the first truly interactive website dedicated to bringing about real awareness of the growing Hepatitis C epidemic.

Here you can share your “C-Story” with others in the community by uploading your personal video. You can also participate in an online dialogue in our online chat room with others affected by the Hepatitis C epidemic.

 

SAVE MONEY ON MEDS

FEATURES: through a top-down, proactive approach we can remain customer focused and goal-directed, innovate and be an inside-out organization which facilitates sticky web-readiness transforming.

PRICE: FREE link to free government programs
It can be lonely at times.
Science can help us live with Hepatitis C

news...

Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform

October 31, 2008

PLEASANTON, Calif., Oct. 30 / PRNewswire
Roche Molecular Diagnostics today announced that the U.S. Food & Drug Administration (FDA) has approved the COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HCV Test for use in the United States. The test uses Roche's proprietary real-time PCR technology to quantify the amount of Hepatitis C RNA in a patient's blood. Physicians use Hepatitis C viral load testing results to establish a baseline level of hepatitis C infection and to serially monitor viral load levels and treatment effectiveness in patients on therapy.
read more

Continue reading "Roche Receives FDA Approval for Hepatitis C Viral Load Test"

posted rehab management
09:20 AM